Mohammad Javad Hosseinzadeh-Attar, MD, PhD


Associate Professor
Department of Clinical Nutrition
School of Nutritional Sciences and Dietetics
Tehran University of Medical Sciences
Tehran, Iran

Biography

Dr. Hosseinzadeh-Attar is currently an Associate Professor in Department of Clinical Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences. With background in Medicine (MD), he completed his PhD from University College London (UCL) in 2004. He also has a postgraduate certificate in Nutritional Medicine from University of Surrey (UK).

Research Interest

His research interests include: Obesity, Clinical nutrition, Adipose tissue, Adipocytokines, Metabolic complication of obesity, Endothelial dysfunction and cardiovascular complications of obesity, Role of adipocytokines in diseases.

Scientific Activities

MEMBERSHIPS

• Member of the Iranian Medical Organization
• Member of Iranian Nutrition Society (ATA)
• Member of European Atherosclerosis Society (EAS)
• Member of the Scientific Board of the 12th Iranian Congress of Biochemistry & the 4th International Congress of Biochemistry & Molecular Biology
• Member of the Scientific Board of the 11th Iranian Nutrition Congress
• Member of the Executive Board of the 10th Iranian Nutrition Congress

Publications

1. Khamin Hamedani N, Hosseinzadeh-Attar MJ, Hosseini M. The correlation between nesfatin-1 and blood pressure in healthy normal weight and obese adults. International Research Journal of Applied and Basic Sciences. 2014; 8(3): 362-364.
2. Tabesh M, Hosseinzadeh-Attar MJ, Tabesh M, Esmaillzadeh A. Effects of Dietary Energy Density on Serum Adipocytokine Levels in Diabetic Women. Horm Metab Res. 2013. doi: 10.1055/s-0033-1353187.
3. Kolahdouz Mohammadi R, Hosseinzadeh-Attar MJ, Eshraghian MR, Nakhjavani M, Khorami E, Esteghamati A. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol. 2013; 59(2): 231-236.
4. Hosseinzadeh-Attar MJ, Golpaie A, Janani L, Derakhshanian H. Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects. Obes Facts. 2013; 6: 193-202. doi: 10.1159/000351162
5. Hosseinzadeh-Attar MJ, Mohammadi S, Karimi M, et al. Association of adiponectin with dietary factors and cardiovascular risk factors in type 2 diabetes mellitus patients. Diabetes Metab Syndr. 2013; 7(1): 3-7. doi: 10.1016/j.dsx.2013.02.027
6. Khorrami E, Hosseinzadeh-Attar MJ, Hosseini M, Emkanjoo Z, Kolahdoz Mohammadi R, Moradmand S. Changes of weight, BMI and waist circumference following fish oil supplementation in patients with persistant and permanent atrial fibrillation. Technical Journal of Engineering and Applied Sciences. 2013; 3(17): 1958-1962.
7. Dehghani S, Hosseinzadeh-Attar MJ, Hosseini M, Salimzadeh A. Decrease of fasting blood sugar via garlic supplementation in postmenopausal obese women with osteoarthritis. International Research Journal of Applied and Basic Sciences. 2013; 5(4): 487-490.
8. Esmaeilzadeh F, Hosseinzadeh-Attar MJ, Hesami O, Hosseini M, Mehrpour M. Effect of quercetin supplementation on blood pressure in patients with a history of ischemic stroke. Technical Journal of Engineering and Applied Sciences. 2013; 3(17): 1963-1966.
9. Alizadeh Z, Kordi R, Rostami M, Mansournia MA, Hosseinzadeh-Attar SM, Fallah J. Comparison between the effects of continuous and intermittent aerobic exercise on weight loss and body fat percentage in overweight and obese women: a randomized controlled trial. Int J Prev Med. 2013; 4(8).
10. Zarrati M, Shidfar F, Nourijelyani K, et al. Lactobacillus acidophilus La5, Bifidobacterium BB12, and Lactobacillus caseiDN001 modulate gene expression of subset specific transcription factors and XII cytokines in peripheral blood mononuclear cells of obese and overweight people. Biofactors. 2013.
11. Zarrati M, Salehi E, Mofid V, et al. Relationship between Probiotic Consumption and IL-10 and IL-17 Secreted by PBMCs in Overweight and Obese People. Iran J Allergy Asthma Immunol. 2013; 12(4): 404-406.
12. Nazemi L, Skoog I, Karlsson I, et al. Depression, prevalence and some risk factors in elderly nursing homes in tehran, iran. Iran J Public Health. 2013; 42(6): 559-569.
13. Derakhshanian H, Djalali M, Djazayery A, Golpaie A, Ekhlasi G, Hosseinzadeh-Attar MJ. Quercetin improves postprandial hyperglycemia in rats treated with high-dose glucocorticoid. Pharmacology Online Journal. 2012; 2: 93-97.
14. Mazaherioun M, Hosseinzadeh-Attar MJ, Janani L, et al. Elevated serum visfatin levels in patients with acute myocardial infarction. Arch Iran Med. 2012; 15(11): 688-692. doi: 0121511/AIM.008
15. Keshavarz SA, Nourieh Z, Hosseinzadeh-Attar MJ, Azadbakht L. Effect of Soymilk Consumption on Waist Circumference and Cardiovascular Risks among Overweight and Obese Female Adults. Int J Prev Med. 2012; 3(11): 798-805.
16. Karbaschian Z, Hosseinzadeh-Attar MJ, Giahi L, et al. Portal and systemic levels of visfatin in morbidly obese subjects undergoing bariatric surgery. Endocrine. 2012.
17. Mostafavi SA, Mohammadi MR, Hosseinzadeh P, et al. Dietary intake, growth and development of children with ADHD in a randomized clinical trial of Ritalin and Melatonin co-administration: Through circadian cycle modification or appetite enhancement? Iran J Psychiatry. 2012; 7(3): 114-119.
18. Mohammadi MR, Mostafavi SA, Keshavarz SA, et al. Melatonin effects in methylphenidate treated children with attention deficit hyperactivity disorder: a randomized double blind clinical trial. Iran J Psychiatry. 2012; 7(2): 87-92.
19. Hosseinzadeh-Atar MJ, Hajianfar H, Bahonar A. The effects of omega-3 on blood pressure and the relationship between serum visfatin level and blood pressure in patients with type II diabetes. Arya Atherosclerosis Journal. 2012; 8(1).
20. Haghighatdoost F, Hosseinzadeh-Attar MJ, Kabiri A, Eshraghian MR, Esmaillzadeh A. Effect of substituting saturated with monounsaturated fatty acids on serum visfatin levels and insulin resistance in overweight women: A randomized cross-over clinical trial. International Journal of Food Sciences and Nutrition. 2012. doi: 10.3109/09637486.2012.665044
21. Golpaie A, Hosseinzadeh-Attar MJ, Hoseini M, Karbaschian Z, Talebpour M. Changes in Lipid Profile and Insulin Resistance in Morbidly Obese Patients Following Laparoscopic Total Gastric Vertical Plication. J Minim Invasive Surg Sci. 2012; 1(1): 24-29.
22. Hosseinzadeh-Attar MJ, Golpaie A, Hosseini M, Darakhshanian H, Talebpour M. Changes of plasma adiponectin level and lipid profile in severely obese patients before and after bariatric surgery. Atherosclerosis Supplements. 2011; 12(1): 13-184.
23. Mohammadi S, Hosseinzadeh-Attar MJ, Hosseinnezhad A, et al. Compare the effects of different visfatin concentration on cardiovascular risk factors, adiponectin and insulin resistance in patients with T2DM. Diabetes Metab Syndr. 2011; 5(2): 71-75. doi: 10.1016/j.dsx.2012.02.014
24. Rezvan N, Hosseinzadeh-Attar MJ, Masoudkabir F, Moini A, Janani L, Mazaherioun M. Serum visfatin concentrations in gestational diabetes mellitus and normal pregnancy. Arch Gynecol Obstet. 2012. doi: 10.1007/s00404-011-2156-7.
25. Golpaie A, Tajik N, Masoudkabir F, et al. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects. Eur Cytokine Netw. 2011; 22(4): 181-186. doi: 10.1684/ecn.2011.0295
26. Hajianfar H, Hosseinzadeh-Attar MJ, Bahonar A, et al. The effect of omega-3 on the serum visfatin concentration in patients with type II diabetes. J Res Med Sci. 2011; 16(4): 490-495.
27. Golpaie A, Hosseinzadeh-Attar MJ. Association between the levels of plasma adiponectin and lipid profile in severely obese patients. Obesity Reviews. 2011; 12(Supp 1).
28. Hosseinzadeh-Attar MJ, Golpaie A, Talebpor M. Effects of weight loss induced by bariatric surgery on visfatin levels. Obesity Reviews. 2011; 12(Suppl1). doi: 10.1016/j.jhep.2009.06.016
29. Mirzaei K, Hosseinzadeh-Attar MJ, Hossein-Nezhad A, et al. Visfatin genotype may influence the effects of green tea extract (Camelliasinensis) in Type 2 diabetes patients. Double blind placebo-controlled clinical trial study. Gazzetta Medica Italiana Archivio per le Scienze Mediche. 2010; 169(4): 137-148.
30. Hosseinzadeh-Attar M, Foroughi M, Zahedi-Asl S. The relationship between visceral obesity and serum concentrations of CRP, IL-6 and visfatin in patients with metabolic syndrome. Clinical Nutrition Supplements. 2009; 4(2): 150.
31. Mirzaei K, Hossein-Nezhad A, Hosseinzadeh-Attar MJ, et al. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Minerva Endocrinol. 2009; 34(4): 273-279.
32. Mirzaei K, Hosseinnezhad A, Hosseinzadeh-Attar M, et al. Relationship between genotype and serum levels of adipokines and bone mineral density in type 2 diabetes mellitus patients. Iranian Journal of Diabetes and Lipid Disorders. 2009; 77-86.
33. Mirzaei K, Hossein-nezhad A, Karimi M, et al. Effect of green tea extract on bone turn over markers in type 2 diabetes patients: double blind placebo-controlled clinical trial study. DARU. 2009; 17(Supp 1): 38-44.
34. Mirzaei K, Hossein-nezhad A, Hosseinzadeh-Attar M, Jafari N, Najmafshar A, Larijani B. Variation in the visfatin gene may alter the required dosage of oral antidiabetic agents in type 2 diabetic patients. Journal of Diabetes and Lipid Disorders. 2009; 87-94.
35. Mohammadi S, Hosseinzadeh-Attar MJ, Hossein-Nezhad A, et al. The prevalence of cardiovascular risk factors and correlation with nutritional status in patient with type 2 Diabetes. Arya atherosclerosis spring. 2009; 5(1): 11-17.
36. Ogston NC, Karastergiou K, Hosseinzadeh-Attar MJ, et al. Low-dose acetylsalicylic acid inhibits the secretion of interleukin-6 from white adipose tissue. Int J Obes (Lond). 2008; 32(12): 1807-1815.
37. Ostberg JE, Storry C, Donald AE, Hosseinzadeh-Attar MJ, Halcox JP, Conway GS. A dose-response study of hormone replacement in young hypogonadal women: effects on intima media thickness and metabolism. Clin Endocrinol (Oxf). 2007; 66(4): 557-564. doi: 10.1111/j.1365-2265.2007.02772.x
38. Mohamed-Ali V, Hosseinzadeh-Attar MJ, Ogston N, et al. Prostacyclin mediated IL-6 and secretion from adipose tissue and adipocytes. Obesity reviews. 2006; 7(Suppl 2): 118.
39. Flachs P, Mohamed-Ali V, Horakova O, et al. Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia. 2006; 49(2): 394-397. doi: 10.1007/s00125-005-0053-y
40. Ostberg JE, Hosseinzadeh-Attar MJ, Mohamed-Ali V, Conway GS. Adipokine dysregulation in turner syndrome: comparison of circulating interleukin-6 and leptin concentrations with measures of adiposity and C-reactive protein. J Clin Endocrinol Metab. 2005; 90(5): 2948-2953. doi: http://dx.doi.org/10.1210/jc.2004-1966
41. Ostberg JE, Thomas EL, Hamilton G, Hosseinzadeh-Attar MJ, Bell JD, Conway GS. Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content. J Clin Endocrinol Metab. 2005; 90(5): 2631-2635. doi: http://dx.doi.org/10.1210/jc.2004-1939
42. Mohamed-Ali V, Hosseinzadeh-Attar MJ, Jowett T, et al. ADMA: A novel signal from adipose tissue linking insulin resistance and endothelial dysfunction. 2005. 43. Hosseinzadeh-Attar MJ. Adipose tissue Release of Interleukin-6 (IL-6) and Asymmetric Dimethyl Arginine (ADMA): Implications for obesity Associated Metabolic Disease. 2004.
44. Hosseinzadeh-Attar MJ, Hurel SJ, Mohamed-Ali V. Adipogenesis and IL-6 secretion from adipose tissue are mediated through different COX isoforms. Abstract in programme and abstracts, 2nd Applied Biology. 2004.
45. Hosseinzadeh-Attar MJ, Hurel SJ, Sampson MJ, Gavrilovic J, Mohamed-Ali V. COX Mediated IL-6 Secretion in Obesity and in Adipose Tissue. 13th European Congress on Obesity (ECO 2004). Abst. Abstract in Obesity Supplement.
46. Ostberg JE, Hosseinzadeh-Attar MJ, Mohamed-Ali V, Conway GS. Glucose Homoeostasis in Turner Syndrome – a unique metabolic defect? Abstract in Program and Abstracts, ENDO. 2004; 2-368.
47. Ostberg JE, Hosseinzadeh-Attar MJ, Mohamed-Ali V, Conway GS. Diabetes Risk in Turner Syndrome – a unique metabolic defect? 23rd Joint Meeting of the BES. Abstract in Endocrine Abstracts. 2004; 7.
48. Hosseinzadeh-Attar MJ, Alipoor E. New insight on Adipose tissue function in advanced renal failure. Obes Res Open J. 2015; 2(1): e5-e7. doi: 10.17140/OROJ-2-e002
49. Alipoor E, Hosseinzadeh-Attar MJ. Obesity induced inflammation-a complex condition. Obes Res Open J. 2015; 2(3): e12-e14.doi: 10.17140/OROJ-2-e005
50. Hosseinzadeh-Attar MJ, Alipoor E, Mehrdadi P. Coenzyme Q10, glucose homeostasis and the probable mediating role of adipokines. Obes Res Open J. 2016; 3(1): e3-e5. doi: 10.17140/OROJ-3-e008